Senior insider sale
See Remarks at FULCRUM THERAPEUTICS, INC. — senior position signals high conviction
$437.9K
45K shares
What this filing means
GOULD ROBERT J plans to sell 45K shares of FULCRUM THERAPEUTICS, INC. valued at approximately $437.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/19/2025ACC: 0001950047-25-009089
DirectorOfficer10% Owner· See Remarks
Since Jul 2019
45K
Shares to sell
$437.9K
Approx. market value
45K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founders Shares
N/A
7/12/2016
45KTotal acquired45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/12/2016 | Founders Shares N/A | 45K | — |
| Total | 45K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
45K
Market value
$437.9K
11/19/2025
Total
Units
45K
Value
$437.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/19/2025 | 45K | $437.9K | NASDAQ | Planned |
| Total | 45K | $437.9K | ||